Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review

Placenta

Volumn 20, Issue 7, 1999, Pages 519-529

  Ray, J G ^a   Laskin, C A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE;

ARTICLE; BLOOD VESSEL; DATA ANALYSIS; FEMALE; HOMOZYGOSITY; HUMAN; INFARCTION; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION;

EID: 0032771090     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.1999.0417     Document Type: Article

References (73)

1. Alperin JB, Haggard ME & McGanity WJ (1969) Folic acid, pregnancy, and abruptio placentae. Am J Clin Nutr, 22, 1354-1361.
2. Ananth CV, Savitz DA, Bowes WA, Jr & Luther ER (1997) Influence of hypertensive disorders and cigarette smoking on placental abruption and uterine bleeding during pregnancy. Br J Obstet Gynaecol, 104, 572-578.
3. Anderson A, Hultberg B, Brattstrom L & Isaksson A (1992) Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem, 30, 377-379.
4. Arnadottir M, Hultberg B, Nilsson-Ehle P & Thysell H (1996) The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest, 56, 41-46.
5. Ashworth JR, Warren AY, Johnson IR & Baker PN (1998) Plasma from pre-eclamptic women and functional change in myometrial resistance arteries. Br J Obstet Gynecol, 105, 459-461.
6. Brenner B & Blumenfeld Z (1997) Thrombophilia and fetal loss. Blood Rev, 11, 72-79.
7. Breslow NE & Day NE (1980) Statistical Methods in Cancer Research. Vol. 1: The Analysis of Case-Control Studies. Oxford, UK: Oxford University Press.
8. Burnand B, Kernan WN & Feinstein AR (1990) Indexes and boundaries for "quantitative significance" in statistical decisions. J Clin Epidemiol, 43, 1273-1284.
9. Chambers JC, McGregor A, Jean-Marie J & Kooner JS (1998) Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet, 351, 36-37.
10. Cnattingius S, Mills JL, Yuen J, Eriksson O & Salonen H (1997) The paradoxical effects of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol, 177, 156-161.
11. Cook DJ, Sackett DL & Spitzer WO (1995) Methodologic guidelines for systematic reviews of randomized control trials in health care from the postdam consultation on meta-analysis. J Clin Epidemiol, 48, 167-171.
12. Czeizel AE & Dudas I (1992) Prevention of the first occurrence of neural-tube defects by periconceptual vitamin supplementation. N Engl J Med, 327, 1832-1835.
13. Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C & van Geijn HP (1995) Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol, 173, 1042-1048.
14. Daly S, Molloy A, Mills J, Lee Y, Conley M, Kirke P, Weir P & Scott J (1998) The influence of 5'10 methylenetetrahydrofolate reductase genotypes on enzyme activity in placental tissue (Abstract). Am J Obstet Gynecol, 178, S23.
15. DerSimonian R & Laird N (1986) Meta-analysis in clinical trials. Controlled Clin Trials, 7, 177-188.
16. de Vries JIP, Dekker GA, Huijgens PC, Jakobs C, Blomberg BME & van Geijn HP (1997) Hyperhomocysteinemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynecol, 104, 1248-1254.
17. DeWolf F, Brosens I & Renaer M (1980) Fetal growth retardation and the maternal arterial supply in the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol, 87, 678-685.
18. Egger M, Schneider M & Davey Smith G (1998) Spurious precision? Meta-analysis of observational studies. Br Med J, 316, 140-144.
19. Erbe RW (1979) Genetic aspects of folate metabolism. Adv Hum Genet, 9, 293-354
20. Friedman S, Shacter A, Eckerling B, Eichhorn F & Rutenberg A (1977) Formino-glutamic acid (Figlu) excretion and abortion. Panminerva Medica, 19, 271-274.
21. Giles C (1966) An acccount of 335 cases of megaloblastic anemia of pregnancy and the puerperium. J Clin Pathol, 19, 1-11.
22. Gimovsky ML, Montoro M & Paul RH (1984) Pregnancy outcomes in women with systemic lupus erythematosus. Obstet Gynecol, 63, 686-689.
23. Giugliani ERJ, Jorge SM & Concalves AL (1985) Serum vitamin B12 levels in parturients, in the intervillous space of the placenta and in full-term newborns and their relationships with folate levels. Am J Clin Nutr, 41, 330-335.
24. Goddijn-Wessel TA, Wouters MG, Els F, van de Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, Boers GH & Eskes TK (1996) Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Reprod Biol, 66, 23-29.
25. Goyette P, Sumner JS, Milos R, Duncan AMV, Rosenblatt DS, Matthews RG & Rozen R (1994) Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nature Genet, 7, 195-200.
26. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G et al. (1997) Plasma homocysteine as a risk factor for vascular disease. JAMA, 211, 1775-1781.
27. Hague B, Whiting M & Tallis G (1998) South Australian experience with hyperhomocysteinaemia as a risk factor in obstetrics. Time for a trial? (Abstract). Neth J Med, 24.
28. Hague B, Crowther C, Robinson J, Dekker G & Odendaal H (1998) Prevention of recurrent pre-eclampsia by folic acid supplementation in women with hyperhomocysteinemia: proposal for a randomized controlled trial. Neth J Med, 52, 24.
29. Hall M & Davidson RJL (1968) Prophylactic folic acid in women with pernicious anaemia after periods of infertility. J Clin Pathol, 21, 599-602.
30. Hibbard BM (1964) The role of folic acid in pregnancy. J Obstet Gynaecol Br Cwlth, 71, 529-541.
31. Hibbard BM (1975) Folates and the fetus. South Afr Med J, 49, 1223-1226.
32. Hibbard BM & Hibbard ED (1963) Aetiological factors in abruptio placentae. Br Med J, 1431-1436.
33. Hibbard BM, Hibbard ED & Jeffcoate TNA (1965) Folic acid and reproduction. Acta Obst Gynecol Scand, 44, 375-400.
34. Hibbard ED (1967) FIGLU excretion in pregnancy. Acta Obstet Gynecol Scand, 46, 61S-69S.
35. Homocysteine Lowering Trialists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ, 316, 894-898.
36. Jackson IMD, Doig WB & McDonald G (1967) Pernicious anemia as a cause of infertility. Lancet, 2, 1159-1160.
37. Kang SS, Wong PWK, Zhou J, Sora J, Lessick M, Ruggie N & Grcevich G (1988) Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease. Metabolism, 37, 611-613.
38. Kang SS, Passen EL, Ruggie N, Wong PW & Sora H (1993) Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation, 88, 1463-1469.
39. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G & Lessing JB (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med, 340, 9-13.
40. 12-deficient rats with emphasis upon intrauterine injury. Am J Physiol, 165, 79-86.
41. Lindheimer MD & Katz AI (1992) Real physiology and disease in pregnancy. In The Kidney: Physiology and Pathophysiology (Eds) Seldin DW, Giebisch G, 2nd edn, pp. 3371-3431. New York: Raven Press.
42. Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B & Lin QR (1997) The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahy drofolate reductase genotypes. Arterioscler Thromb Vase Biol, 17, 1157-1162.
43. Martin JD, Davis RE & Steinhouse N (1967) Serum folate and vitamin B12 levels in pregnancy with particular reference to uterine bleeding and bacteriuria. J Obstet Gynaecol Br Cwlth, 74, 697-701.
44. Martin RH, Harper TA & Kelso W (1965) Serum-folic-acid in recurrent abortions. Lancet, 670-672.
45. Metz J, McGrath K, Bennett M, Hyland K & Bottiglieri T (1995) Biochemical indices of vitamin B12 nutrition in pregnant patients with subnormal vitamin B12 levels. Am J Hematol, 48, 251-255.
46. Miller RK, Faber W, Asai M, D'Gregorio RP, Ng WW, Shah Y & Neth-Jessee L (1993) The role of the human placenta in embryonic nutrition. Impact of environmental and social factors. Ann NY Acad Sci, 678, 92-107.
47. MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet, 338, 131-137.
48. Neiger R, Wise C, Contag SA, Tumber MB & Canick JA (1993) First trimester bleeding and pregnancy outcome in gravidas with normal and low folate levels. Am J Perinatol, 10, 460-462.
49. Nelen WL, Steegers EA, Eskes TK & Blom HJ (1997) Genetic risk factor for unexplained recurrent early pregnancy loss. Lancet, 350, 861.
50. Nelen WLD, Bulten J, Blom HJ, Steegers EAP, Hanselaar AGJ & Eskes TKA (1998) Association between chorionic villous vascularization and homocysteine concentration in women with unexplained recurrent pregnancy loss? Neth J Med, 52, 57.
51. Nygard O, Vollset SE, Refsum H, Stensvold I, Tverdal A, Nordrehaug JE, Ueland M & Kvale G (1995) Total plasma homocysteine and cardiovascular risk profile. The Hordaland homocysteine study. JAMA, 274, 1526-1533.
52. Owen EP, Human L, Carolissen AA, Harley EH & Odendaal HJ (1997) Hyperhomocysteinemia - a risk factor for abruptio placentae. J Inher Metab Dis, 20, 359-362.
53. Petri M, Roubenoff R, Dallal GE, Nadeau MR, Selhub J & Rosenberg IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet, 348, 1120-1124.
54. Petitti DB (1994) Meta-analysis, Decision Analysis, and Cost-effective Analysis: Methods for Quantitative Synthesis in Medicine. New York, NY: Oxford University Press.
55. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR & Roberts JM (1998) Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol, 179, 1605-1611.
56. Rajkovic A, Catalano PM & Mlinow MR (1997) Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol, 90, 168-171.
57. Raymond EG & Mills JL (1993) Placental abruption. Maternal risk factors and associated fetal conditions. Acta Obstet Gynecol Scand, 72, 633-639.
58. Redman CWG (1991) Current topic: pre-eclampsia and the placenta. Placenta, 12, 301-308.
59. 6 from diet and supplements in relation to risk of coronary artery disease among women. JAMA, 279, 359-364.
60. Roberts JM, Taylor RM & Goldfein A (1991) Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypertens, 4, 700-708.
61. Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, Psaty BM, Longstreth WT Jr, Koepsell TD, Raghunathan TE & Reitsma PH (1997) Myocardial infarction in young women in relation to plasma total homocysteine, folate, a common variant in the methylenetetrahydrofolate reductase gene. Circulation, 96, 412-417.
62. Shapiro S (1994) Meta-analysis/shmeta analysis. Am J Epidemiol, 140, 771-778.
63. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H & Kubo T (1997) Methylenetertrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet, 34, 525-526.
64. Sorensen TK, Malinow MR, Williams MA, King IB & Luthy DA (1998) Elevated second trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia (Abstract). Am J Obstet Gynecol, 178. S108.
65. Streiff RR & Little AB (1967) Folic acid deficiency in pregnancy. N Engl J Med, 276, 776-779.
66. Streiner DL (1998) Risky business: making sense of estimates of risk. Can J Psychiatry, 43, 411-415.
67. Sutterlin M, Bussen S, Ruppert D & Steck T (1977) Serum levels of folate and cobalamin in women with recurrent spontaneous abortion. Hum Reprod, 12, 2292-2296.
68. Van der Molen EF, Nelen WLD, Heil SG, Eskes TKA & Blom HJ (1998) The mutation 677C→T of the methylenetetrahydrofolate reductase (MTHFR) gene as a possible risk factor for placental vasculopathy. Neth J Med, 52, 28.
69. Welch GN & Loscalzo J (1998) Homocysteine and atherosclerosis. N Engl J Med, 338, 1042-1051.
70. Whalley PJ, Scott DE & Pritchard JA (1969) Maternal folate deficiency and pregnancy wastage. I. Placental abruption. Am J Obstet Gynecol, 105, 670-678.
71. Whalley PJ, Scott DE & Pritchard JA (1970) Maternal folate deficiency and pregnancy wastage. III. Pregnancy-induced hypertension. Obstet Gynecol, 36, 29-31.
72. Whitehead AS, Gallagher P, Mills JL, Burke H, et al (1995) A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Q J Med, 88, 763-766.
73. Wouters MG, Boers GH, Blom HJ, Trijbels, FJ, Thomas CM, Borm GF, Steegers-Theunissen RP & Eskes TK (1993) Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril, 60, 820-825.